BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Holding BBIO?
Track your performance easily

BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?

993 Followers

BridgeBio Pharma (BBIO) Ownership Overview

20.75%15.80%2.93%13.31%47.21%
20.75% Insiders
2.93% Other Institutional Investors
13.31% ETFs
47.21% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 32.05% of the company’s stock is owned by Institutional Investors, 20.75% is owned by Insiders, and 47.21% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
xxxxxxxxxxxxx
$149350000
Feb 13, 2024
xxxxxxxxxxxxx
$44476

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,260,971Insider13.43%684,319,704
25,120,991Institution13.36%680,527,646
13,476,430Institution7.17%365,076,489
12,152,418Institution6.46%329,209,004
9,959,504Insider5.59%269,802,963
6,971,554Institution3.71%188,859,398
6,068,125Institution3.23%164,385,506
2,855,513Institution1.52%77,355,847
1,571,173Institution0.84%42,563,077
1,553,457Institution0.83%42,083,150

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
12,152,418Institution6.46%329,209,004
1,571,173Institution0.84%42,563,077
1,553,457Institution0.83%42,083,150
1,490,722Institution0.79%40,383,659
1,310,481Institution0.70%35,500,930
802,299Institution0.43%21,734,280
802,019Institution0.43%21,726,695
787,327Institution0.42%21,328,688
699,643Institution0.37%18,953,329
673,688Institution0.36%18,250,208

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,528,732Institution2.41%115,301,517
3,831,182Institution2.04%103,786,720
3,529,086Institution1.88%89,850,530
2,743,846Institution1.46%71,010,734
2,211,780Institution1.18%56,311,919
1,946,710Institution1.04%49,563,237
991,373Institution0.53%26,856,295
790,395Institution0.42%21,411,801
707,451Institution0.38%18,308,832
644,634Institution0.34%16,412,382

FAQ

Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 2.93% of the company's stock is held by institutional investors, 20.75% is held by insiders, and 47.21% is held by retail investors.
    What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.93% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
      What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 47.21% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
        Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
        KKR Genetic Disorder L.P. owns the most shares of BridgeBio Pharma Inc (BBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis